Lyrica

Bloomberg Businessweek (Asia) - - FOCUS ON / PHARMA -

Pfzer has in­creased dis­counts on its Lyrica medicine for nerve pain. Be­cause the drug has few close com­peti­tors, Pfzer was able to raise the list price faster, re­sult­ing in a net gain of about 85 per­cent dur­ing the pe­riod.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.